Synthetic Dataset Generation

KerusCloud® can be used to generate highly realistic synthetic datasets for use in a wide variety of analytics applications in the life sciences sector and beyond.

The KerusCloud® platform has proved to be a core part of our decision-making as it allows us to prospectively tailor study designs as new information becomes available.
Biotech, UK
Chief Medical Officer

Generate Synthetic Clinical Data for Smarter, Safer Research

KerusCloud® offers advanced synthetic data generation for clinical research, helping teams simulate realistic patient-level datasets without compromising privacy. Whether you’re designing trials, building external control arms, or training AI models, KerusCloud® enables you to generate high-quality data that mirrors real-world conditions. This empowers faster, safer decision-making—especially when access to real data is limited, sensitive, or incomplete.


What is synthetic data?

Synthetic data is data which has been generated using purpose-built computer simulations, mathematical/statistical models or algorithms. Synthetic data is generated to meet specific needs or certain conditions that may not be found in the original, real data. It has many applications across multiple industries including:

  • Market research and business intelligence
  • Testing and validating software products and systems
  • Building and testing algorithms
  • Predictive modelling, machine learning and AI
When is it useful for clinical trials?

Synthetic data is useful in clinical research, where it can be used:

  • In clinical trial design optimization to maximize chance of success.
  • To create external control arms for clinical trials to save time and resources.
  • In anonymization to enable the sharing of regulated or sensitive data.
  • To create large, auto labelled data for predictive modelling, machine learning and AI to address issues of imbalanced data.
How do we create it?

Within KerusCloud® is a synthetic data generator. It can handle diverse and complex data collected from disparate data sources and produce synthetic datasets from them. KerusCloud’s exceptional modelling capability allows it to incorporate realistic characteristics into the synthetic datasets it produces such as missing data, truncation and censoring. It can model the inter-correlation between subject-level data such as subgroups and strata, risk factors/covariates and multiple outcomes and data types. This delivers a highly realistic synthetic version of the original data.

Suggested For You

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

perspectives

June 17th, 2025

Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise

regulatory intelligence

June 16th, 2025

Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting

perspectives

June 10th, 2025

Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives 

perspectives

June 3rd, 2025

Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions 

news

May 28th, 2025

MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award 

perspectives

May 28th, 2025

A Season of Change: Why the REMS Industry Consortium Matters More Than Ever

perspectives

May 20th, 2025

Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution